I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

WCN 2026

We will be contributing to topics related to
-
04:25 PM
Duration 10mins Yokohama, Japan
B-cell-targeted therapy for idiopathic nephrotic syndrome: results of the Phase III global multicenter INSHORE trial evaluating efficacy and safety of obinutuzumab vs mycophenolate mofetil
Julien Hogan, Larry A. Greenbaum, Kandai Nozu, Malgorzata Mizerska-Wasiak, Andreia Watanabe, Andrea Angeletti, Kenneth Lieberman, Jie Ding, Uchimura Toru, Franz Schaeffer, Theodore A. Omachi, Ben Lanza, Benoît Meger, Heather Boston, Patricia B. Lehane, for the INShore Study Group
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 AM
Duration 60mins Yokohama, Japan
Population PK/PD modeling to assess ethnic sensitivity in the clinical development of sefaxersen
Sylvie Retout, Takakazu Sato, Qingqing Xiao, Felix Jaminion, Vishal Duggal, Nikhil Kamath, Jeannette Lo, Nelson Guerreiro
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Yokohama, Japan
Pharmacokinetics, pharmacodynamics, safety and tolerability of sefaxersen in Chinese healthy participants: a randomized, open-label, parallel-group, phase 1 study
Xia Zhao, Nan Zhao, Tianyu Zhou, Qingqing Xiao, Jia Shi, Na Zhao, Chang Liu, Lili Zhang, Nikhil Kamath, Vishal Duggal
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 AM
Duration 60mins Yokohama, Japan
Obinutuzumab Induces Histologic Remission and Deep Kidney Parenchymal B-Cell Depletion in Patients With Lupus Nephritis: Exploratory Analyses of the Regency Trial
Brad H. Rovin, Elsa Martins, Cary D. Austin,Harini Raghu, Caleb Chan, Patrick S. Chang, Valeria Alberton, Mittermayer B. Santiago, Gustavo Aroca-Martínez, Jose Alfaro, Richard A. Furie, Christopher Larsen, Bongin Yoo, William F. Pendergraft, Ana Malvar
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Yokohama, Japan
Evaluation of Pathophysiology Biomarkers in Kidney Biopsies Collected in IMAgINATION, A Phase 3 Study of Sefaxersen in Patients with IgAN
Jonathan Barratt, Loreto Gesualdo, Dana V Rizk, Hua Li, Irene Noronha, Vishal Duggal, Nadine Schmit, Nikhil Kamath, Amanda Nash, Naron (Roop) Sasenarine, Chang Liu, Jeannette Lo
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon